These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
8. Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease. Malinowska A; Chmurzynska A Nutr Res; 2009 Oct; 29(10):685-95. PubMed ID: 19917447 [TBL] [Abstract][Full Text] [Related]
9. [Homocysteine. The cardiovascular risk factor of the next millennium?]. Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543 [TBL] [Abstract][Full Text] [Related]
10. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. McKinley MC Proc Nutr Soc; 2000 May; 59(2):221-37. PubMed ID: 10946791 [TBL] [Abstract][Full Text] [Related]
11. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12]. Alemán G; Tovar AR; Torres N Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110 [TBL] [Abstract][Full Text] [Related]
12. Homocysteine-lowering treatment: an overview. van Guldener C; Stehouwer CD Expert Opin Pharmacother; 2001 Sep; 2(9):1449-60. PubMed ID: 11585023 [TBL] [Abstract][Full Text] [Related]
13. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. Olthof MR; van Vliet T; Verhoef P; Zock PL; Katan MB PLoS Med; 2005 May; 2(5):e135. PubMed ID: 15916468 [TBL] [Abstract][Full Text] [Related]
14. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism. Semmler A; Moskau-Hartmann S; Stoffel-Wagner B; Elger C; Linnebank M Clin Chem Lab Med; 2013 Mar; 51(3):665-9. PubMed ID: 23382314 [TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia--a risk factor for development of occlusive vascular diseases]. Milosević-Tosić M; Borota J Med Pregl; 2002; 55(9-10):385-91. PubMed ID: 12584890 [TBL] [Abstract][Full Text] [Related]
16. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene. Vilaseca MA; Monrós E; Artuch R; Colomé C; Farré C; Valls C; Cardo E; Pineda M Eur J Paediatr Neurol; 2000; 4(6):269-77. PubMed ID: 11277368 [TBL] [Abstract][Full Text] [Related]
17. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Clarke R; Armitage J Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852 [TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor]. Caramia G; Belardinelli R Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine and cardiovascular disease: a review of the evidence. Wierzbicki AS Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449 [TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia and cardiovascular disease in animal model. Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]